This article was originally published May 4.
Olerup, a Swedish provider of genomic HLA typing kits, will distribute HLA sequencing-based typing products and analysis software for Conexio of Australia.
In addition, the two companies plan to co-develop new HLA typing products.
Under the exclusive, global five-year agreement, Olerup will market, sell, and distribute Conexio's SBT Resolver products, which are locus-specific PCR-based HLA sequencing-based typing reagents. The agreement also includes a version of Conexio's Assign sequence analysis software.
Olerup SSP said the SBT product line represents a "strong complement" to its own HLA typing technology and will be sold through its sales channels and sub-distributors.
"We looked at several different options for our SBT Resolver product line and sequence analysis software and felt that collaboration with Olerup SSP would enable us to best provide high-quality solutions to HLA-typing laboratories," said Conexio co-founder and CEO David Sayer in a statement.
Conexio, based in Western Australia, develops sequencing technology for HLA typing and mutation detection. According to the company, more than 100 research and hospital laboratories worldwide currently use its sequence analysis software and SBT reagents, which are sold under license through other firms.